Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines
- PMID: 2451917
- DOI: 10.1016/s0006-291x(88)80727-7
Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines
Abstract
The insulin like growth factors (IGFs), potent mitogens for a variety of normal and transformed cells, have been reported to be secreted by several human breast cancer cell lines (BC). We have investigated the binding characteristics of IGF-I and -II in four human BC: MCF-7, T-47D, MDA 231 and Hs578T. Binding studies in microsomal membrane preparations detected high specific binding for both IGF in all four BC studied. Cross-linking with 125I-IGF-I, followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under reduced conditions, revealed the presence of an alpha subunit of apparent Mr = 130,000 in MCF-7, T-47D and MDA 213 cells. When 125I-IGF-II was cross-linked, a major band of apparent Mr = 260,000 was seen in all BC. This band was inhibited by IGF-II, but not by insulin. Cross-linking of 125I-IGF-I to conditioned media from BC demonstrated the presence of three binding proteins of apparent Mr = 45,000, 36,000 and 29,000 in all BC but T-47D, in which the 36,000 band was not seen. These data demonstrate that BC possess classical receptors for both IGF-I and -II and, furthermore, that BC produce specific binding proteins for these growth factors.
Similar articles
-
Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.J Clin Endocrinol Metab. 1988 Jan;66(1):173-80. doi: 10.1210/jcem-66-1-173. J Clin Endocrinol Metab. 1988. PMID: 2961785
-
Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.Endocrinology. 1985 Nov;117(5):2008-16. doi: 10.1210/endo-117-5-2008. Endocrinology. 1985. PMID: 2995005
-
Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells.Endocrinology. 1989 Jan;124(1):388-96. doi: 10.1210/endo-124-1-388. Endocrinology. 1989. PMID: 2462492
-
Somatomedin/insulin-like growth factor tissue receptors.Clin Endocrinol Metab. 1984 Mar;13(1):43-67. doi: 10.1016/s0300-595x(84)80008-0. Clin Endocrinol Metab. 1984. PMID: 6202447 Review.
-
Insulin-like growth factor (IGF)/somatomedin receptor subtypes: structure, function, and relationships to insulin receptors and IGF carrier proteins.Horm Res. 1986;24(2-3):152-9. doi: 10.1159/000180554. Horm Res. 1986. PMID: 2944811 Review.
Cited by
-
Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers.Br J Clin Pharmacol. 1994 Sep;38(3):213-9. doi: 10.1111/j.1365-2125.1994.tb04344.x. Br J Clin Pharmacol. 1994. PMID: 7826822 Free PMC article. Clinical Trial.
-
Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis.Br J Cancer. 1992 Aug;66(2):248-53. doi: 10.1038/bjc.1992.252. Br J Cancer. 1992. PMID: 1323990 Free PMC article.
-
Tamoxifen reduces serum insulin-like growth factor I (IGF-I).Breast Cancer Res Treat. 1992;22(1):91-100. doi: 10.1007/BF01833337. Breast Cancer Res Treat. 1992. PMID: 1421427 Review.
-
Autocrine growth factors and solid tumor malignancy.West J Med. 1991 Aug;155(2):152-63. West J Med. 1991. PMID: 1926844 Free PMC article. Review.
-
Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.Br J Cancer. 1993 Aug;68(2):282-9. doi: 10.1038/bjc.1993.329. Br J Cancer. 1993. PMID: 8347483 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical